Oncimmune Holdings PLC (LSE:ONC) - Overview

Stock Report

Oncimmune Holdings PLC ONC

Last Price
GBX134.00

Day Change
0.00|0.00%

As of 08/12/2016
11:07:47 GMT | GBX
Minimum 15 Minutes Delay.

Last Close134.00p
Day Range135.00 - 135.00
Mkt Cap68.37Mil
52-Wk Range105.00 - 140.00
Yield %0.00
ISINGB00BYQ94H38
Volume2,000
P/E-5.48
P/S111.76
P/CF-15.14

Share Price

Total Returns 09/12/2016

 Chg (%)  
More ...
Oncimmune Holdings PLC23.50 
FTSE 100 TR GBP1.73
 
Financials
201420152016
More ...
Income Statement
Turnover1.061.350.43
Operating Profit-2.76-1.38-5.71
Net Profit-1.41-2.01-8.44
Reported EPS-2.77-3.95-23.54
Balance Sheet
Current Assets2.421.8710.82
Non Current Assets0.070.080.38
Total Assets2.481.9511.21
Current Liabilities1.111.641.08
Total Liabilities4.365.771.48
Total Equity-1.88-3.829.73
Cash Flow
Operating Cash Flow-2.31-1.40-3.75
Net Change in Cash0.56-0.318.93
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-6.50-10.19--13.15---
2018-4.20-5.10--26.25---

Company Profile

Oncimmune Holdings PLC is a cancer detection company engaged in developing and commercializing its proprietary EarlyCDT platform technology. Its product EarlyCDT-Lung is a simple blood test to aid the risk assessment and early detection of lung cancer.
 

Sector

Diagnostics & Research

Market Position

982 of 1863 Companies

Index

Outlook

(07/11/2016) ch - "...we believe we are well positioned to generate significant value"

Next Event 30/01/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)-17.8013.3915.97
Div Yld (E)0.004.244.18
PEG (E)0.000.220.27
ROCE-81.99204.18-30.67
Op Mrgn-1,041.86-17.37-33.06
EPS Grwth0.009.7722.66
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Meinhard Schmidt
Chief Executive OfficerMr. Geoffrey Hamilton-Fairley
Chief Financial Officer & Company SecretMr. Andrew Millet
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.